2020
DOI: 10.1016/j.colcom.2020.100244
|View full text |Cite
|
Sign up to set email alerts
|

Emerging trends in clinical implications of bio-conjugated silver nanoparticles in drug delivery

Abstract: From nanopharmaceutics to renewable energy, silver nanoparticles (AgNPs) present innumerable applications in the contemporary era. However, the associated toxicity to the biosystems limits their application. Effective utilization of AgNPs, therefore, requires their surface conjugation with biologically benevolent moieties that enhance the bio-acceptability of silver-based nanosystems, and supplementary functionalities for further extension of their unique applications. The clinical importance of AgNPs was esta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
37
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 110 publications
(43 citation statements)
references
References 188 publications
1
37
0
Order By: Relevance
“…The two most used systems of metal NPs are gold (AuNPs) and silver (AgNPs) due to their broad-spectrum activities [169]. These systems offer suitable strategies for delivering AMPs, as both counterparts are usually of low molecular weight.…”
Section: Metallic Npsmentioning
confidence: 99%
“…The two most used systems of metal NPs are gold (AuNPs) and silver (AgNPs) due to their broad-spectrum activities [169]. These systems offer suitable strategies for delivering AMPs, as both counterparts are usually of low molecular weight.…”
Section: Metallic Npsmentioning
confidence: 99%
“…The two most used systems of metal NPs are gold (AuNPs) and silver (AgNPs) due to their broad-spectrum activities [140]. This system offers suitable strategies for delivering AMPs as both counterparts are usually of low molecular weight.…”
Section: Metallic Npsmentioning
confidence: 99%
“…Therefore, people are actively developing antibiotics‐free strategies or low‐dose precise drug‐delivery treatment strategies. [ 14,15 ] Antibacterial biomaterials have been emerging as a potential substitute of antibiotics for the treatment of bacterial infectious diseases. [ 16 ] Antibacterial materials have been widely used in the treatment and repair of infectious skin wounds, [ 17 ] infections related to the reconstruction of infectious bone defect tissues, [ 18 ] as well as the treatment of other infectious diseases, such as bacterial pneumonia, [ 19 ] prevention of bacterial infections of bone implants, [ 20 ] and the surface antibacterial research of materials.…”
Section: Introductionmentioning
confidence: 99%